Life sciences specialists from Tilleke & Gibbins have supplied the Thailand and Vietnam contributions to the International Bar Association (IBA) Healthcare and Life Sciences Law Committee's global telemedicine survey.

The Employment Department in Thailand has officially announced that Work Permit applications filed under the Board of Investment,

Across the globe, the demand for COVID-19 vaccinations has been understandably high, with many regulatory authorities issuing emergency use authorizations for COVID-19 vaccines.

One of the more positive outcomes of the COVID-19 pandemic is that telemedicine has become remarkably important as an interactive system between patients and healthcare professionals.

Thailand's Food and Drug Administration (FDA) has launched a strategic collaboration with leading e-commerce platforms Lazada and Shopee to strengthen regulatory oversight of health-related products...

Thailand’s new labeling requirements for medical devices, which include for the first time a unique device identification (UDI) requirement for software as a medical device (SaMD), take effect on June 20, 2026.

Laos' Food and Drug Department (FDD) has been using a new online registration system for drugs since the beginning of the year.

On December 30, 2025, Thailand's Electronic Transactions Development Agency (ETDA) notified digital marketplace operators of a consolidated list of "high‑risk products" that are subject...

Effective August 19, 2019, all initial and renewal work permit applications to Thailand, including those filed under the Board of Investment (BOI)

Cannabis (both marijuana and hemp) has been classified as a Category 5 Narcotic since the enactment of the Narcotics Act in 1979.

In an ever-evolving world where health and wellness take center stage, Thailand has emerged as a beacon of hope and innovation in the global healthcare landscape.

The updated Thailand chapter of The Pharma Legal Handbook, published by Pharma Boardroom, is a comprehensive guide to the legal framework regulating the healthcare and life sciences industries in Thailand.

Liberal cannabis access in Thailand is officially over. On June 26, 2025, the Ministry of Public Health brought the inflorescence of cannabis back under tight control through its new Notification on Controlled Herbs (Cannabis) 2025 ("Notification 2025").

Attorneys from Tilleke & Gibbins in Bangkok have provided updates for the latest edition of The Pharma Legal Handbook: Thailand, published by Pharma Boardroom.

As a complementary concept, a telepharmacy allows a pharmacist to verify prescriptions, counsel patients, and dispense medication from a remote site.

On August 5, 2026, the Consumer Case Division of Thailand’s Civil Court rendered a judgment in a case involving a beauty clinic that advertised acne scar treatments using claims that the clinic was operated by a specialist physician and that the treatment, allegedly involving stem cell technology, could permanently remove acne scars.

A new Good Manufacturing Practice requires manufacturers to have a prompt and effective system for drug product recalls.

Government Regulation No. 28 of 2024 ("GR No. 28") was issued on July 26, 2024, to implement Law No. 17 of 2023 on Health (the "Omnibus Health Law"). GR No. 28 contains extensive provisions on tobacco products...

The Ministry of Public Health (MOPH) in Thailand has issued an updated regulation on food labeling, published in the Government Gazette on July 18, 2024, taking effect from 19 July 2024.

Pharmaceutical companies seeking to enter the Thai market must navigate a complex regulatory landscape encompassing marketing authorization, pharmacovigilance obligations, and licensing requirements administered by Thailand's Food and Drug Administration. This comprehensive guide examines the registration pathways, review timelines, data protection rules, and post-approval obligations that govern pharmaceutical products in Thailand. Understanding these regulatory frameworks is essential for companies planni